Citadel Advisors
PCYC

Citadel Advisors’s PHARMACYCLICS INC PCYC Stock Holding History

Citadel Advisors’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-136,400
Closed -$34.9M – 9444
2015
Q1 		$34.9M Buy
136,400
+52,100
+62% +$10.1M 0.03% 660
2014
Q4 		$10.3M Buy
84,300
+4,500
+6% +$575K 0.01% 1375
2014
Q3 		$9.37M Buy
79,800
+24,200
+44% +$2.76M 0.01% 1417
2014
Q2 		$4.99M Sell
55,600
-21,000
-27% -$1.97M 0.01% 1835
2014
Q1 		$7.68M Sell
76,600
-32,200
-30% -$4.19M 0.01% 1446
2013
Q4 		$11.5M Buy
108,800
+62,100
+133% +$7.54M 0.02% 1121
2013
Q3 		$6.46M Buy
46,700
+12,800
+38% +$1.42M 0.01% 1391
2013
Q2 		$2.69M Buy
+33,900
New +$2.77M ﹤0.01% 2174

Other funds holding PCYC

Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Citadel Advisors's PCYC Position: Q2 2015 in Review

Citadel Advisors sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 2,152 shares — an estimated $551K sold.

Citadel Advisors first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $16.6M in Q3 2014. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • Citadel Advisors reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • Citadel Advisors sold 2,152 PHARMACYCLICS INC shares in Q2 2015, an estimated $551K.
  • Citadel Advisors first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • Citadel Advisors's PHARMACYCLICS INC position peaked at $16.6M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.